Zydus Cadila has received final approval from the US health regulator to market Lansoprazole capsules used for treating ulcers and other conditions involving excessive stomach acid. The company now has 81 approvals and has so far filed 186 abbreviated new drug applications (ANDAs) since the commencement of filing process in FY’2003-2004. The firm has global operations spread across the US, Europe, Japan, Brazil, South Africa and 25 other emerging markets.
Project Value
Refer document
Clearances Approved
Not Specified
India
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
